Aligos Therapeutics Cash Flow Statement (2019-2026) | ALGS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-29.82M	-33.12M	-37.71M	-35.62M	-19.92M	-18.62M	-21.89M	-22.95M	-18.79M	-18.04M	-27.89M	-34.86M	5.06M	-19.26M	-82.15M	43.09M	-15.86M	-31.54M	-19.88M	-23.04M
Depreciation and Depletion (Quarter)	0.80M	0.80M	0.71M	0.68M	0.60M	0.50M	0.51M	0.45M	0.40M	0.30M	0.36M	0.30M	0.30M	0.30M	0.21M	0.20M	0.30M	0.20M	0.23M	0.30M
Share-based Compensation (Quarter)	3.45M	3.59M	3.65M	3.79M	3.99M	3.49M	3.42M	3.66M	3.20M	3.21M	2.58M	2.65M	2.06M	2.04M	1.71M	0.96M	1.16M	1.47M	1.46M	1.31M
Gains from Sales and Divestitures (Quarter)	0.18M	0.25M	0.32M	0.07M	0.09M	0.09M	0.09M					0.00M	0.00M	0.00M
Gains from Investment Securities (Quarter)	0.08M		-0.38M	0.03M		0.66M	0.06M	0.54M		2.15M	1.07M	14.37M			62.13M	0.03M	0.04M	0.07M	0.00M	0.06M
Asset Writedowns and Impairment (Quarter)									0.70M
Non-cash Items (Quarter)	47.14M	1.46M	16.76M	0.12M	2.77M	3.20M	3.73M	4.46M	4.86M	5.47M	6.05M	3.08M	3.44M	0.15M	10.61M	0.25M	0.03M	1.19M	0.86M	0.21M
Cash from Operations (Quarter)	-23.02M	-25.37M	-37.48M	-20.43M	-25.04M	-17.14M	-16.78M	-22.39M	-13.62M	-20.34M	-22.66M	-22.75M	-19.49M	-20.10M	-18.40M	-20.91M	-15.50M	-24.34M	-21.75M	-23.13M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.02M	-0.00M	-0.02M	-0.01M	0.02M	0.07M	0.07M	0.39M	0.03M	0.70M	-0.70M	0.39M	0.35M	0.42M	0.62M	0.32M	0.72M	0.35M	0.81M	0.42M
Depreciation & Amortization (CF) (Quarter)	0.80M	0.80M	0.71M	0.68M	0.60M	0.50M	0.51M	0.45M	0.40M	0.30M	0.36M	0.30M	0.30M	0.30M	0.21M	0.20M	0.30M	0.20M	0.23M	0.30M
Change in Working Capital
Change in Account Payables (Quarter)	-1.33M	1.12M	0.40M	0.74M	-0.99M	0.17M	1.81M	-1.92M	0.42M	-0.30M	-0.42M	0.33M	3.98M	-4.08M	-0.17M	1.73M	-0.40M	0.75M	-0.67M	3.66M
Change in Accured Expenses (Quarter)	-0.00M	0.00M	-0.13M	0.00M	-12.43M	0.90M	11.39M	-0.94M	-1.26M	-1.46M	4.58M	-4.80M	0.02M	2.10M	1.29M	-4.76M	1.41M	1.40M	-0.08M	-1.54M
Other Working Capital Changes (Quarter)	-2.15M	2.71M	7.81M	-3.62M	12.37M	-14.91M	4.35M	-2.09M	-2.17M	0.78M	-4.66M	-0.20M	-1.06M	0.61M	-2.03M	-0.15M	-1.35M	-0.80M	2.20M	-0.32M
Investing Activities
Capital Expenditures (Quarter)	0.15M	0.10M	0.34M	0.52M	0.33M	0.00M	0.09M	0.01M
Change in Acquisitions & Divestments (Quarter)			13.00M			37.45M	36.22M	20.00M	25.00M	0.01M				30.00M	20.00M	20.00M		70.00M	37.50M	35.00M
Cash from Investing Activities (Quarter)	9.85M	-0.04M	-16.48M	-60.40M	-9.98M	32.48M	11.60M	19.99M	25.00M	-0.01M	-0.01M	-88.64M	39.99M	10.40M	19.97M	-44.07M	-39.42M	47.68M	-2.02M	34.93M
Financing Activities
Cash from Financing Activities (Quarter)	0.10M	77.95M	0.55M	-0.02M	0.08M	-0.02M	0.12M	-0.00M	0.41M	-0.02M	87.94M	-0.02M	0.28M	-0.00M	0.10M	101.74M	-0.18M	-0.05M	0.12M	-0.06M
Additional items
Change in Cash (Quarter)	-13.07M	52.54M	-53.41M	-80.86M	-34.93M	15.33M	-5.06M	-2.40M	11.80M	-20.37M	65.27M	-111.41M	20.78M	-9.71M	1.67M	36.77M	-55.10M	23.29M	-23.64M	11.74M
Free Cash Flow (Quarter)	-23.17M	-25.46M	-37.82M	-20.95M	-25.37M	-17.14M	-16.87M	-22.39M	-13.62M	-20.34M	-22.66M	-22.75M	-19.49M	-20.10M	-18.40M	-20.91M	-15.50M	-24.34M	-21.75M	-23.13M
Net Cash Flow (Quarter)	-13.07M	52.54M	-53.41M	-80.86M	-34.93M	15.33M	-5.06M	-2.40M	11.80M	-20.37M	65.27M	-111.41M	20.78M	-9.71M	1.67M	36.77M	-55.10M	23.29M	-23.64M	11.74M

Research Tools

Developers

Aligos Therapeutics Cash Flow Statement (2019-2026) | ALGS

Research Tools

Developers

Aligos Therapeutics Cash Flow Statement (2019-2026) | ALGS

Create an account

Sign In

Reset Password